The comprehensive evaluation of the immunometabolic phenotype of tumour microenvironment in breast cancer.
Investigation of the underlying biology and immunomodulatory effects of anti-PD1 and metformin combination using targeted transcriptomics and multiplex immunohistochemistry in a breast tumour murine model.
